Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_assertion type Assertion NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_head.
- NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_assertion description "[Therefore, concomitant administration of HDACIs and ERK1/2 inhibitors may be a promising treatment strategy for individuals with GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_provenance.
- NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_assertion evidence source_evidence_literature NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_provenance.
- NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_assertion SIO_000772 22781708 NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_provenance.
- NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_assertion wasDerivedFrom befree-20150227 NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_provenance.
- NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_assertion wasGeneratedBy ECO_0000203 NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_provenance.